Federal Circuit Confirms Joined IPR Petitioners Have Standing for Appellate Review and that Lead-Compound Analysis Is a Fact-Intensive Inquiry By C. Collette Corser Drew D. Christie on February 4, 2019 Email this postTweet this postLike this postShare this post on LinkedIn Decision: Mylan Pharm. Inc. v. Research Corp. Techs., Inc., Nos. 2017-2088, 2017-2089, 2017-2091 (Fed. Cir. Feb. 1, 2019). Read more
